WARREN LEX LLP
`Matthew S. Warren (State Bar No. 230565)
`Erika H. Warren (State Bar No. 295570)
`Sachli Balazadeh-Nayeri (State Bar No. 341885)
`2261 Market Street, No. 606
`San Francisco, California 94114
`Telephone: 415-895-2940
`Facsimile: 415-895-2964
`
`WILLIAMS & CONNOLLY LLP
`David I. Berl*
`Adam D. Harber*
`Elise M. Baumgarten*
`Melissa B. Collins*
`D. Shayon Ghosh (Cal. Bar No. 313628)
`Arthur John Argall III*
`Andrew G. Borrasso*
`680 Maine Avenue SW
`Washington, DC 20024
`Telephone: 202-434-5000
`Facsimile: 202-434-5029
`* Admitted pro hac vice
`
`Attorneys for Plaintiffs Gentex Corp. and
`Indigo Technologies, LLC
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No.: 22-cv-03892-YGR
`
`PLAINTIFFS’ DISCLOSURE OF
`ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`PURSUANT TO PATENT L.R. 3-1
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF CALIFORNIA
`
`
`Plaintiffs,
`
`Involuntary Plaintiff,
`
`
`
`
`
`v.
`
`
`GENTEX CORPORATION and INDIGO
`TECHNOLOGIES, LLC,
`
`
`
`THALES VISIONIX, INC.,
`
`
`
`
`
`META PLATFORMS, INC. and META
`PLATFORMS TECHNOLOGIES, LLC,
`
`
`
`
`
`
`Defendants.
`
`
`
` Case No. 22-cv-3892-YGR
`
`
`PLAINTIFFS’ DISCLOSURE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`
`
`Pursuant to Patent L.R. 3-1 and the Court’s Case Management and Pretrial Order (Dkt. No.
`116), Plaintiffs Gentex Corporation and Indigo Technologies, LLC (collectively, “Gentex”) hereby
`serve their Disclosure of Asserted Claims and Infringement Contentions.
`These infringement contentions are preliminary. Defendants Meta Platforms, Inc. and Meta
`Platforms Technologies, LLC (collectively, “Meta”) have not yet provided any information or
`technical documents other than source code, and Gentex’s investigation is ongoing. The Court also
`has not yet construed any of the asserted claims. Gentex specifically reserves its right to supplement
`these disclosures—including by asserting additional claims, accusing different or additional
`functionality, and accusing additional and/or different products—based on the Court’s claim
`construction, pursuant to Patent Local Rule 3-6(a), or based on information obtained, including
`through discovery, as the case progresses, pursuant to Patent Local Rule 3-6(c). Gentex also
`reserves the right to amend its infringement contentions and asserted claims based on the concurrent
`proceedings before the U.S. Patent & Trademark Office regarding the asserted patents.
`As set forth in detail in Gentex’s Complaint and the Exhibits attached thereto (Dkt. No. 1),
`Gentex alleges that Meta has infringed and continues to infringe, directly and indirectly, literally or
`under the doctrine of equivalents, one or more claims of U.S. Patent Nos. 6,757,068 (the“’068
`patent”), 7,301,648 (the “’648 patent”), 8,224,024 (the “’024 patent”), 6,922,632 (the “’632 patent”),
`and 7,725,253 (the “’253 patent”) (collectively, the “Asserted Patents”).
`I.
`IDENTIFICATION OF ASSERTED CLAIMS (PATENT L.R. 3-1(A))
`Based upon presently known information, Gentex alleges that Meta has infringed and
`continues to infringe the following claims (collectively, the “Asserted Claims”) of the Asserted
`Patents both literally and under the doctrine of equivalents, in violation of 35 U.S.C. §§ 271(a), (b),
`and (c):
`
`
`
`
`
`
`
`’068 patent: Claims 1-2, 4-5, 7-8, 11-12, 14-20, 23-33, 35, 41, 45-48, 50, 54, and 56-59
`’648 patent: Claims 1-5, 8-11, 16-18, 20-32, 35, 37-38, and 40-44
`’024 patent: Claim 1
`’632 patent: Claims 1-2, 5-8, 24-25, 28-29, 47, 50-53, and 59-61
`’253 patent: Claims 1-4, 6, and 7-9
` Case No. 22-cv-3892-YGR
`
`1
`PLAINTIFFS’ DISCLOSURE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`II.
`
`
`IDENTIFICATION OF ACCUSED INSTRUMENTALITIES (PATENT L.R. 3-1(B))
`Based upon presently known information, Gentex alleges that Meta has infringed and
`continues to infringe the Asserted Patents by making, using, selling, offering to sell, and/or
`importing its Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2 products (collectively,
`with their respective related instructions, systems, services, and software, the “Accused Products”).1
`For a table listing each claim separately, see infra Table 1.
`III. CLAIM CHARTS FOR THE ASSERTED PATENTS (PATENT L.R. 3-1(C)–(E))
`Gentex attaches as Exhibits 1-5 claim charts identifying the manner in which the Accused
`Products infringe each element of the asserted claims. The charts further include, for each claim that
`is alleged to have been indirectly infringed, an identification of any direct infringement and a
`description of Meta’s actions that contribute to or are inducing that direct infringement based on
`presently known information. The charts also include, for each claim that is allege to have been
`directly infringed based on joint acts of multiple parties, the role of each such party in the direct
`infringement based on presently known information. The charts further specify which claim
`elements are literally present in the Accused Products and which claim elements are present under
`the doctrine of equivalents.
`These claim charts are based on a reasonable investigation of information currently available
`to Gentex. These infringement contentions are intended to serve a notice function, and do not
`constitute an exhaustive explanation of all theories Gentex may present in this case. Gentex reserves
`the right to amend, revise, alter, or otherwise modify these charts as this case progresses, including
`to incorporate new information obtained during the course of discovery pursuant to Patent L.R. 3-
`6(c).
`
`Exhibit 1 sets forth Gentex’s contentions concerning Meta’s direct and indirect infringement
`of the Asserted Claims of the ’068 patent, including a chart setting forth where in the Accused
`
`1 Gentex understands that Meta will release a new product, Meta Quest Pro, on October 25, 2022.
`See Meta, Introducing Meta Quest Pro, an Advanced VR Device for Collaboration and Creation,
`Oculus Blog (Oct. 11, 2022), https://www.oculus.com/blog/meta-quest-pro-price- release-date/.
`Once the Meta Quest Pro is released, Gentex reserves the right to update these contentions and
`pleadings as appropriate.
`
` Case No. 22-cv-3892-YGR
`2
`
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`Products each element of the claims is found, to the best of Gentex’s current knowledge and
`information.
`Exhibit 2 sets forth Gentex’s contentions concerning Meta’s direct and indirect infringement
`of the Asserted Claims of the ’648 patent, including a chart setting forth where in the Accused
`Products each element of the claims is found, to the best of Gentex’s current knowledge and
`information.
`Exhibit 3 sets forth Gentex’s contentions concerning Meta’s direct and indirect infringement
`of claim 1 of the ’024 patent, including a chart setting forth where in the Accused Products each
`element of the aforementioned claim is found, to the best of Gentex’s current knowledge and
`information.
`Exhibit 4 sets forth Gentex’s contentions concerning Meta’s direct and indirect infringement
`of the Asserted Claims of the ’632 patent, including a chart setting forth where in the Accused
`Products each element of the claims is found, to the best of Gentex’s current knowledge and
`information.
`Exhibit 5 sets forth Gentex’s contentions concerning Meta’s direct and indirect infringement
`of the Asserted Claims of the ’253 patent, including a chart setting forth where in the Accused
`Products each element of the claims is found, to the best of Gentex’s current knowledge and
`information.
`The Court has not yet construed the Asserted Claims. Depending on any constructions by the
`Court as to the Asserted Claims, and/or positions that Meta or its expert witness(es) may take
`concerning claim interpretation, infringement, and/or validity issues, the charts in Exhibit 1–5 and
`the disclosures referenced therein may be of greater or lesser relevance, and different disclosures
`relating to the Accused Products may be implicated. Given this uncertainty, the charts may reflect
`alternative applications of the claims to the Accused Products. Nothing stated herein shall be
`construed as an admission or a waiver of any particular construction of any claim term.
`
`
`
`
` Case No. 22-cv-3892-YGR
`3
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`IV.
`
`
`THE PRIORITY DATE TO WHICH EACH ASSERTED CLAIM IS ENTITLED
`(PATENT L.R. 3-1(F))
`Gentex contends that the Asserted Claims of the ’068 patent are entitled to a priority date of
`January 28, 2000, the date of the filing of Provisional Application No. 60/178,797, to which the ’068
`patent claims priority.
`Gentex contends that the Asserted Claims of the ’648 patent are entitled to a priority date of
`January 28, 2000, the date of the filing of Provisional Application No. 60/178,797, to which the ’648
`patent claims priority.
`Gentex contends that claim 1 of the ’024 patent is entitled to a priority date no earlier than
`July 14, 2005, or in the alternative, no later than the October 4, 2005 filing of Provisional
`Application No. 60/723,648, to which the ’024 patent claims priority.
`Gentex contends that the Asserted Claims of the ’632 patent are entitled to a priority date no
`earlier than June 13, 2001, or in the alternative, no later than the August 9, 2002 filing of Provisional
`Application No. 60/402,178, to which the ’632 patent claims priority.
`Gentex contends that the Asserted Claims of the ’253 patent are entitled to a priority date no
`earlier than June 13, 2001, or in the alternative, no later than the August 9, 2002 filing of Provisional
`Application No. 60/402,178, to which the ’253 patent claims priority.
`Gentex’s investigation is ongoing, and not all materials related to the conception and
`reduction to practice of the Asserted Claims are in its possession. Gentex reserves the right to
`amend its contentions regarding the priority dates of the Asserted Claims, including to identify and
`establish earlier dates, based on information learned as the case progresses.
`V.
`GENTEX PRODUCTS THAT PRACTICE THE CLAIMED INVENTIONS (PATENT
`L.R. 3-1(G))
`Gentex does not presently intend to rely on the assertion that its or its licensee’s current
`apparatus, product, device, process, method, act, or other instrumentality practices the claimed
`invention. Gentex’s investigation is ongoing, however, and not all materials related to the practice
`of the claimed inventions are in its possession. In particular, Gentex is aware that, during the
`approximately one year that Gentex owned Intersense, Inc., Intersense sold products marked as
`practicing one or more of the Asserted Patents, including the IS-900 PCI, IS-900 VE Tracker, IS-900
`
` Case No. 22-cv-3892-YGR
`
`4
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`SimTracker, and IS-1200 VisTracker. Gentex’s investigation into the operation of these and other
`Intersense products is ongoing. Gentex has produced certain documents reflecting the operations (to
`the extent it is aware) of such products and the marking of such products with one or more of the
`Asserted Patents, e.g., with Bates Numbers GNTX0002091–GNTX0002206 and GNTX0002457–
`GNTX0002573. Gentex reserves the right to amend its contentions regarding practicing
`instrumentalities, including to identify additional instrumentalities, based on information learned as
`the case progresses.
`VI.
`TIMING OF FIRST INFRINGEMENT (PATENT L.R. 3-1(H))
`Based upon presently known information, Gentex alleges that Meta infringed the Asserted
`Patents by selling and/or offering to sell the Accused Products at least as early as April 30, 2019,
`when Meta began taking preorders for the Oculus Rift S and Oculus Quest devices. Furthermore,
`Meta continued to infringe the Asserted Patents by selling and/or offering to sell the Accused
`Products as early as September 16, 2020, when it began taking preorders for the Oculus Quest 2
`(later renamed Meta Quest 2). Accordingly, based on presently known information, Gentex’s
`damages for infringement of all of the Asserted Patents began on April 30, 2019. Damages for
`infringement of the ’068 and ’648 patents, respectively, ended on the date when those patents
`expired inclusive of any patent term adjustment or any other extensions or adjustments. For the
`’068 patent, that was May 13, 2022, and for the ’648 patent, that was January 26, 2021. Damages
`for infringement of the ’024 patent, the ’632 patent, and the ’253 patent are each ongoing and will
`not end until Meta either stops infringing those patents, or on the date of the expiration of those
`patents inclusive of any patent term adjustment or other extensions or adjustments. Discovery is
`ongoing, and Meta has not yet produced any documents relating to when it began making, using,
`selling, offering to sell, and/or importing the Accused Products. Gentex reserves the right to amend
`its contentions regarding the timing of first infringement, start of claimed damages, and end of
`claimed damages, based on information learned as the case progresses.
`VII. BASIS FOR ALLEGATION OF WILLFUL INFRINGEMENT (PATENT L.R. 3-1(I))
`Gentex alleges that Meta’s infringement has been and continues to be willful, and the basis
`for Gentex’s allegation is set forth in Paragraphs 52-62 of its Complaint, which are incorporated by
`
` Case No. 22-cv-3892-YGR
`
`5
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`reference here. Discovery is ongoing, and Meta has not yet produced any documents relating to its
`knowledge of the Asserted Patents. Gentex reserves the right to amend its contentions regarding
`willful infringement based on information learned as the case progresses.
`VIII. DOCUMENT PRODUCTIONS (PATENT L.R. 3-2)
`A.
`Documents Evidencing Conception and Reduction to Practice (Patent L.R. 3-
`2(b))
`Gentex has produced certain documents evidencing conception and reduction to practice of
`the inventions claimed in the ’024, ’632, and ’253 patents with Bates numbers GNTX0001534–
`GNTX0001604. Gentex is working with and will continue to work with the relevant third parties to
`locate any additional documents evidencing conception and reduction to practice of the claimed
`inventions and to produce them promptly.
`B.
`File Histories (Patent L.R. 3-2(c))
`Gentex has produced a copy of the file histories for each of the Asserted Patents with Bates
`numbers GNTX0000031–GNTX0000904.
`C.
`Ownership of and Transfers of Interest in the Patents-in-Suit (Patent L.R. 3-2(d)
`and (f))
`
`Gentex has produced documents within its possession, custody, and control located after a
`reasonable search, including documents that evidence Gentex’s ownership of rights in the Asserted
`Patents and agreements, including licenses, transferring an interest in any Asserted Patent, with
`Bates numbers GNTX000001–GNTX0000030 and GNTX0001207–GNTX0001533.
`D.
`Comparable Licenses and Other Agreements (Patent L.R. 3-2(g) and (h))
`Gentex has conducted a reasonable search and has not located any other agreements within
`its possession, custody, or control that it contends are comparable to a license that would result from
`a hypothetical reasonable royalty negotiation, or that otherwise may be used to support its damages
`case. Discovery is ongoing, and Meta has not yet produced any licensing or other agreements
`relevant to damages. Gentex reserves the right to amend its contentions regarding comparable
`licenses and other agreements based on information learned as the case progresses.
`
`
`
`
` Case No. 22-cv-3892-YGR
`6
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`E.
`Documents Pursuant to Patent L.R. 3-2(a) and (j)
`Gentex has conducted a reasonable search, and has not located any documents covered by
`Patent L.R. 3-2(a). The Asserted Patents are not subject to any F/RAND commitments or
`agreements; accordingly, Patent L.R. 3-2(j) is not applicable.
`
`
`
`
`
`
` Case No. 22-cv-3892-YGR
`7
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`Table 1
`
`
`
`Patent Asserted Claim Accused Instrumentalities
`’068
`1
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`2
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`4
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`5
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`7
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`8
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`11
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`12
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`14
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`15
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`16
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`17
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`18
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`19
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`20
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`23
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`24
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`25
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`26
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`27
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`28
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`29
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`30
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`31
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`32
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`33
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`35
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`41
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`45
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`46
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`47
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`48
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`50
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`54
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`56
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`57
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`58
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’068
`59
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`
`
`
`
`
`
`
`
` Case No. 22-cv-3892-YGR
`8
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`Patent Asserted Claim Accused Instrumentalities
`’648
`1
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`2
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`3
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`4
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`5
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`8
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`9
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`10
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`11
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`16
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`17
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`18
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`20
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`21
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`22
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`23
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`24
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`25
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`26
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`27
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`28
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`29
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`30
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`31
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`32
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`35
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`37
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`38
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`40
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`41
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`42
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`43
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’648
`44
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’024
`1
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`1
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`2
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`5
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`6
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`7
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`8
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`
`
`
`
`
`
`
`
` Case No. 22-cv-3892-YGR
`9
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`
`
`
`Patent Asserted Claim Accused Instrumentalities
`’632
`24
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`25
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`28
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`29
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`47
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`50
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`51
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`52
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`53
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`59
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`60
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’632
`61
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`1
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`2
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`3
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`4
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`6
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`8
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`’253
`9
`Oculus Rift S, Oculus Quest, Oculus Quest 2, and Meta Quest 2
`
`
`
`
`
`
`
`
` Case No. 22-cv-3892-YGR
`10
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`

`

`
`Dated: October 21, 2022
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Adam D. Harber
`
`WARREN LEX LLP
`Matthew S. Warren (State Bar No. 230565)
`Erika H. Warren (State Bar No. 295570)
`Sachli Balazadeh-Nayeri (State Bar No. 341885)
`2261 Market Street, No. 606
`San Francisco, California 94114
`Telephone: 415-895-2940
`Facsimile: 415-895-2964
`
`WILLIAMS & CONNOLLY LLP
`David I. Berl*
`Adam D. Harber*
`Elise M. Baumgarten*
`Melissa B. Collins*
`D. Shayon Ghosh (State Bar No. 313628)
`Arthur John Argall III*
`Andrew G. Borrasso*
`680 Maine Avenue SW
`Washington, DC 20024
`Telephone: 202-434-5000
`Facsimile: 202-434-5029
`* Admitted pro hac vice
`
`Attorneys for Plaintiffs Gentex Corp. and Indigo
`Technologies, LLC
`
`
`
` Case No. 22-cv-3892-YGR
`11
`PLAINTIFFS’ DISCLOUSRE OF ASSERTED CLAIMS AND
`INFRINGEMENT CONTENTIONS
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`
`
`
`
`
`
`META 1037
`IPR2022-01304
`META V. THALES
`
`